(Q38005913)

26 August 2017

The role of cell lines in the study of neuroendocrine tumors (English)

1 reference

26 August 2017

0 references

Simona Grozinsky-Glasberg

series ordinal

1

1 reference

26 August 2017

Ilan Shimon

series ordinal

2

1 reference

26 August 2017

Hadara Rubinfeld

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

7 June 2012

1 reference

26 August 2017

1 reference

26 August 2017

96

1 reference

26 August 2017

173-187

1 reference

26 August 2017

3

1 reference

describes a project that uses

26 August 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment

1 reference

Neuroendocrine neoplasms of the gut and pancreas: new insights

21 January 2018

1 reference

Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors

21 January 2018

1 reference

Recent advances in carcinoid pathogenesis, diagnosis and management

21 January 2018

1 reference

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

21 January 2018

1 reference

Experimental pathology and the origins of tissue culture: Leo Loeb's contribution

21 January 2018

1 reference

Genetics of neuroendocrine and carcinoid tumours

21 January 2018

1 reference

Pituitary cell lines and their endocrine applications.

21 January 2018

1 reference

Oberndorfer and his successors: from carcinoid to neuroendocrine carcinoma

21 January 2018

1 reference

A 5-decade analysis of 13,715 carcinoid tumors

21 January 2018

1 reference

Enterochromaffin cells of the digestive system: cellular source of guanylin, a guanylate cyclase-activating peptide

21 January 2018

1 reference

Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole

21 January 2018

1 reference

Current status of gastrointestinal carcinoids

21 January 2018

1 reference

A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake

21 January 2018

1 reference

Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract

21 January 2018

1 reference

Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease

21 January 2018

1 reference

Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude mice

21 January 2018

1 reference

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters

21 January 2018

1 reference

The functional characterization of normal and neoplastic human enterochromaffin cells

21 January 2018

1 reference

KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.

21 January 2018

1 reference

Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin

21 January 2018

1 reference

Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT.

21 January 2018

1 reference

Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells

21 January 2018

1 reference

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

21 January 2018

1 reference

In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor

21 January 2018

1 reference

Angiogenesis and tumor progression in neuroendocrine digestive tumors

21 January 2018

1 reference

The development and characterization of a human midgut carcinoid cell line

21 January 2018

1 reference

Varying opinions on the authenticity of a human midgut carcinoid cell line--letter

21 January 2018

1 reference

Analysis of multiple molecular changes in human endocrine tumours

21 January 2018

1 reference

Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells

21 January 2018

1 reference

Functional CRF receptors in BON cells stimulate serotonin release.

21 January 2018

1 reference

Spectral karyotypic and comparative genomic analysis of the endocrine pancreatic tumor cell line BON-1.

21 January 2018

1 reference

Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth.

21 January 2018

1 reference

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1)

21 January 2018

1 reference

Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum

21 January 2018

1 reference

The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms

21 January 2018

1 reference

Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/

21 January 2018

1 reference

Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells.

21 January 2018

1 reference

Perturbations of the AKT signaling pathway in human cancer

21 January 2018

1 reference

The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells

21 January 2018

1 reference

Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors

21 January 2018

1 reference

Clinical and in vitro studies of imatinib in advanced carcinoid tumors

21 January 2018

1 reference

Effects of the tyrosine kinase inhibitor imatinib on neuroendocrine tumor cell growth

21 January 2018

1 reference

Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs

21 January 2018

1 reference

Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors

21 January 2018

1 reference

Five new insulin-producing cell lines with differing secretory properties

21 January 2018

1 reference

Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM.

21 January 2018

1 reference

Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells

21 January 2018

1 reference

Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor

21 January 2018

1 reference

Regulation of insulinoma cell proliferation and insulin accumulation by peptides and second messengers.

21 January 2018

1 reference

Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells

21 January 2018

1 reference

p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells

21 January 2018

1 reference

Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells

21 January 2018

1 reference

Karyotype of the human insulinoma CM cell line--beta cell model in vitro?

21 January 2018

1 reference

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line

21 January 2018

1 reference

Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.

21 January 2018

1 reference

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

21 January 2018

1 reference

The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value

21 January 2018

1 reference

Xenoimplantation using a diffusion chamber with a B-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP).

21 January 2018

1 reference

Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors

21 January 2018

1 reference

Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide

21 January 2018

1 reference

Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway

21 January 2018

1 reference

Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro

21 January 2018

1 reference

Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells

21 January 2018

1 reference

Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells

21 January 2018

1 reference

Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors.

21 January 2018

1 reference

Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt

21 January 2018

1 reference

Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line

21 January 2018

1 reference

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells

21 January 2018

1 reference

Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity

21 January 2018

1 reference

Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs

21 January 2018

1 reference

Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer

21 January 2018

1 reference

Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft

21 January 2018

1 reference

Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1.

21 January 2018

1 reference

Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma

21 January 2018

1 reference

Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines

21 January 2018

1 reference

Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.

21 January 2018

1 reference

A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.

21 January 2018

1 reference

Cox-2 promotes chromogranin A expression and bioactivity: evidence for a prostaglandin E2-dependent mechanism and the involvement of a proximal cyclic adenosine 5'-monophosphate-responsive element

21 January 2018

1 reference

Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance

21 January 2018

1 reference

A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants

21 January 2018

1 reference

Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.

21 January 2018

1 reference

Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy

21 January 2018

1 reference

First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338793

1 reference

26 August 2017

1 reference